Objective: Lung cancer is the most common cancer type in men overall our country. It is fourth one in women after breast, thyroid and colorectal cancers. Enviromental factors have important role on the etiology such as tobacco is responsible from 80-90%. Namely as determined in epidemiological studies smokers has risk of lung cancer 20 times higher than non-smokers. Despite these knowledge near one million people worldwide are guessed to be tobacco smokers. Our aim in this study is to define distribution of lung cancer cases over 65 years and smoking ratios.
Materials and Methods: 128 patients over 65 years involved the study from 351 lung cancer patients living in our region and referred to our clinic between 2015-2018. File records included clinical symptoms, histopathological data, clinical staging data, tobacco smoking habits, personal background, family history, applied treatment procedures and survival durations of the cases.
Results: In our study 93.8 % (n=120) of the patients were men and 6.2% (n=8) were women. Mean age was 72.4±6.9 (65-87) years. Coughing (41,3%) was the mostly seen clinical symptom. Education data showed they were mostly (66,6%) graduated from primary school. 7,8% of them were non literated. We have seen carpenter, driver, miner and employee in our patients mainly (39,5%). Additionally 26,9% were farmer, 17,6% were tradespeople and 16% were whitecollar workers. Smoking ratio was 87,4% (n:97) in our lung cancer cases over 65 years. And 54,1% of these were smoking 2 packets/day, 19,8% were smoking 1 packet/day, 13,5% were smoking 3 packets/day. Duration of smoking was over 30 years in 72,1% of them. In lung cancer people over 65 years mostly seen histological subtype was squamosus cell cancer at 37,6% (n:46), adenocancer was at 30,1% (n:37), large cell cancer was at 14,6% (n:20), small cell cancer was at 16,3% (n:23) and mixed type was at 1,6% (n:2). Significant relation has found between smoking and histologycal type. Smokers had squamosus cell cancer (40,9%) whereas non-smokers had adenocancer (78,6%) mostly. 66,7% of the cases, most of them, were stage 4 at time of diagnose (n:84). 10,2% had performed surgery ,35,2% recieved chemoradiotherapy, 47,7% received chemotherapy and 12,5% had only received radiotherapy. In our clinic paclitaxel/carboplatin was used frequently 42,5% (n:37) as chemotherapy regimes in over 65 years. Overall survival were 339,440±424,494 days and progression free survival were 311,040±481,434 in our cases.
Conclusion : Smoking rates are high in patients over 65 years with lung cancer living in our city. Stage of disease was mostly high at diagnose. Because of increasing treatment costs in addition to high mortality rates of lung cancer, we should support smoking cessation companies.